The Hedgehog Inhibitor Cyclopamine Reduces β-Catenin-Tcf Transcriptional Activity, Induces E-Cadherin Expression, and Reduces Invasion in Colorectal Cancer Cells-Reference-Cited by-同舟云学术

The Hedgehog Inhibitor Cyclopamine Reduces β-Catenin-Tcf Transcriptional Activity, Induces E-Cadherin Expression, and Reduces Invasion in Colorectal Cancer Cells

Published:2015-09-17 Issue:3 Volume:7 Page:1885-1899
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Qualtrough David,Rees Phil,Speight Beverley,Williams Ann,Paraskeva Christos

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Link

http://www.mdpi.com/2072-6694/7/3/0867/pdf

Reference38 articles.

1. Worldwide Cancer Mortality Statisticshttp://www.cancerresearchuk.org/health-professional/cancer-statistics/worldwide-cancer/mortality-heading-One

2. Linking Colorectal Cancer to Wnt Signaling

3. Migrating cancer stem cells — an integrated concept of malignant tumour progression

4. Hallmarks of Cancer: The Next Generation

5. Hedgehog Signaling in Development and Homeostasis of the Gastrointestinal Tract

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mapping the intricacies of GLI1 in hedgehog signaling: A combined bioinformatics and clinical analysis in Head & Neck cancer in Western India;Current Problems in Cancer;2024-12

2. Wnt/β-Catenin Signaling Pathway in Pediatric Tumors: Implications for Diagnosis and Treatment;Children;2024-06-07

3. Gut bacteria promote proliferation in benign S/RG/C2 colorectal tumour cells, and promote proliferation, migration and invasion in malignant HCT116 cells;Scientific Reports;2023-10-12

4. Unraveling dynamic interactions between tumor-associated macrophages and consensus molecular subtypes in colorectal cancer: An integrative analysis of single-cell and bulk RNA transcriptome;Heliyon;2023-09

5. Transforming Growth Factor and the Role of Epigenetic Aberrancies in Oncogenic Amplifications: A New Perspective in Preventive and Therapeutic Arena;Journal of Cancer Therapy;2023